James River’s Myron returns CEO role to Abram due to health
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free Trial
  • Log in

James River’s Myron returns CEO role to Abram due to health

James River CEO Robert Myron is stepping down as CEO due to lingering effects from Lyme disease, according to the company.

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Gift this article